{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "EU ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Source:
NCT00418795: Phase 2/Phase 3 Interventional Completed Acute Intermittent Porphyria
(2003)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03578809: Phase 2 Interventional Completed ST Elevation Myocardial Infarction
(2018)
Source URL:
Class:
PROTEIN
Class:
PROTEIN
Status:
Investigational
Source:
NCT03512314: Phase 3 Interventional Completed XIAP Deficiency
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03587311: Phase 2 Interventional Active, not recruiting Fallopian Tube Endometrioid Adenocarcinoma
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02472977: Phase 1/Phase 2 Interventional Terminated Solid Tumor
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02550873: Phase 2 Interventional Completed Idiopathic Pulmonary Fibrosis
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:efpegsomatropin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01439971: Phase 1 Interventional Completed Hemophilia A
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02226146: Phase 2 Interventional Completed Pemphigoid, Bullous
(2016)
Source URL:
Class:
PROTEIN
